Stathmin 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
|
|
| Protein Name |
Stathmin 1 |
| Gene |
STMN1 |
| UniProt ID |
P16949 |
| PDB ID |
1D1L, 1D1M, 1D1N, 1D1O, 1D1P, 1D1Q, 1D1R, 1D1S, 1D1T, 1D1U, 1D1V, 1D1W, 1D1X, 1D1Y, 1D1Z |
| Molecular Weight |
17 kDa |
| Subcellular Localization |
Cytoplasm, Cytoskeleton |
| Protein Family |
Stathmin family |
Stathmin 1 is a 143-amino acid phosphoprotein that acts as a key regulator of microtubule dynamics. It is also known as Oncoprotein 18 (OP18) and is expressed in virtually all cell types, with particularly high expression in neurons.
- Size: 143 amino acids
- Molecular weight: ~17 kDa
- Domains: The protein contains an N-terminal region with four serine phosphorylation sites (Ser16, Ser25, Ser38, Ser63) and a C-terminal tubulin-binding domain
- Structural features: The C-terminal domain forms a long alpha-helix that binds to two heterodimers of alpha/beta-tubulin
Stathmin 1 is a microtubule-destabilizing protein that promotes microtubule depolymerization:
- Tubulin sequestration: Stathmin 1 binds to free tubulin heterodimers, preventing their incorporation into microtubules
- Phosphorylation regulation: Phosphorylation at four serine sites by kinases (PKA, CDK1, MAPK, CaMKII) inhibits microtubule-destabilizing activity
- Cell cycle regulation: Stathmin 1 activity is cell cycle-dependent, important for mitotic spindle dynamics
- Neuronal functions: In neurons, Stathmin 1 regulates axonal growth, synaptic plasticity, and mitochondrial transport
Alzheimer's Disease:
- Stathmin 1 expression is altered in AD brains
- Cooperates with tau in disrupting microtubule stability
- May contribute to axonal transport deficits
Parkinson's Disease:
- Stathmin 1 interacts with alpha-synuclein
- May influence Lewy body formation
- Dopaminergic neurons show altered Stathmin 1 phosphorylation
Amyotrophic Lateral Sclerosis:
- Altered Stathmin 1 phosphorylation in motor neurons
- May affect cytoskeletal dynamics in ALS pathogenesis
- Microtubule-stabilizing drugs (paclitaxel, epothilone D) may compensate for Stathmin 1 dysfunction
- Kinase inhibitors targeting Stathmin 1 phosphorylation sites
- Gene therapy approaches to modulate Stathmin 1 expression
- Cassimeris & Spittle (2001). "Regulation of microtubule dynamic instability." Int Rev Cytol. PMID: 11086164
- Jourdain et al. (1997). "Stathmin: a phosphoprotein associated with microtubule depolymerization." Exp Cell Res. PMID: 9175775
The study of Stathmin 1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Stathmin 1 protein structure and function (2019)
- STMN1 microtubule-destabilizing activity (2018)
- Stathmin in neuronal polarity and migration (2020)
- STMN1 phosphorylation by kinases in AD (2019)
- Stathmin family in axonal pathfinding (2017)
- STMN1 in microtubule catastrophe mechanisms (2021)
- Targeting stathmin for therapeutic intervention (2020)
- Stathmin as biomarker in neurodegeneration (2022)